US Stock MarketDetailed Quotes

RPRX Royalty Pharma

Watchlist
  • 28.070
  • -0.310-1.09%
Close May 14 16:00 ET
  • 28.070
  • 0.0000.00%
Post 16:20 ET
12.66BMarket Cap15.77P/E (TTM)

Royalty Pharma Key Stats

Royalty Pharma Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 9, 2024

Revenue(YoY)

567.98M

-16.96%
EPS(YoY)

0.01

-98.68%

Strong Buy

May 14, 2024

Royalty Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 683.004M--
--2024/Q2-- / 603.203M--
May 9, 20242024/Q1568.000M / 709.445M--
Feb 15, 20242023/Q4596.000M / 674.541M--
Nov 8, 20232023/Q3536.313M / 618.492M--
Aug 8, 20232023/Q2538.000M / 536.594M--
May 9, 20232023/Q1684.000M / 629.653M--
Feb 15, 20232022/Q4566.000M / 1.097B--
Nov 8, 20222022/Q3573.000M / 610.321M--
Aug 4, 20222022/Q2536.000M / 533.903M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 683.004M--
--2024/Q2-- / 603.203M--
May 9, 20242024/Q1568.000M / 709.445M--
Feb 15, 20242023/Q4596.000M / 674.541M--
Nov 8, 20232023/Q3536.313M / 618.492M--
Aug 8, 20232023/Q2538.000M / 536.594M--
May 9, 20232023/Q1684.000M / 629.653M--
Feb 15, 20232022/Q4566.000M / 1.097B--
Nov 8, 20222022/Q3573.000M / 610.321M--
Aug 4, 20222022/Q2536.000M / 533.903M--

Unlock Free Earnings Estimates

Royalty Pharma Earnings Reports

Read more

Analysis

Analyst Rating

Updated: May 14, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg